BioSpace News Archive

“Today, the Government of Canada released national-level modelling on the COVID-19 epidemic in Canada. The modelling attempts to show how the epidemic might unfold over the coming months based on our knowledge of how the virus behaves and the potential impact of public health measures.

DaVita Kidney Care stands with the National Kidney Foundation and its open letter urging hospitals and health systems not to limit care to end stage kidney disease (ESKD) patients with COVID-19 who need life-saving interventions.

CrossRoads® Extremity Systems announces the launch of miniBunion™, a minimally-invasive technique and system to repair painful bunions.

NeoImmuneTech, Inc. , a clinical-stage T cell-focused biopharmaceutical company, today announced it has entered into a clinical collaboration agreement with Bristol Myers Squibb (NYSE: BMY) to evaluate the combination of NeoImmuneTech’s NT-I7 (also known as Hyleukin-7™), a long-acting IL-7, and Bristol Myers Squibb’s Opdivo® (nivolumab), a PD-1 blocking antibody. The goal of the Phase 2 study is to establish safety

Groundbreaking Registry Aims to Help Researchers Accelerate COVID-19 Diagnosis, Treatment and Prevention Strategies

Pfizer and BioNTech to jointly develop COVID-19 vaccine, initially in the United States and Europe, and scale-up manufacturing capacity to support global supply

Pfizer and BioNTech enter into collaboration agreement to co-develop potential COVID-19 vaccine

Neos Therapeutics, Inc. announced that the United States Patent and Trademark Office has issued U.S. Patent No. 10,610,507, which is directed to methods of treating sialorrhea by administering N-desethyloxybutynin, the active pharmaceutical ingredient in NT0502.

Many women with metastatic hormone receptor-positive breast cancer have experienced improved clinical outcomes with the recent introduction of alpelisib, a PIK3CA inhibitor.

Fresenius Medical Care, the world’s leading provider of dialysis products and services, has released an advisory calling for clinical care principles on access to be upheld for patients with advanced chronic kidney disease if a surge in COVID-19 infections overwhelms the available supply of facilities, caregivers and ventilators.